Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals (NQ: AGIO )

52.77 USD -0.15 (-0.28%)
Official Closing Price Updated: 4:00 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 422,600
Open 52.87
Bid (Size) 50.24 (5)
Ask (Size) 53.99 (5)
Prev. Close 52.92
Today's Range 51.91 - 52.91
52wk Range 32.47 - 58.93
Shares Outstanding 57,605,621
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Agios Announces Closing of Oncology Business Sale to Servier
From GlobeNewswire News Releases
Agios Shareholders Approve Sale of Oncology Business to Servier
From GlobeNewswire News Releases

Performance

YTD
+19.12%
+19.12%
1 Month
+5.18%
+5.18%
3 Month
+12.95%
+12.95%
6 Month
+48.15%
+48.15%
1 Year
+32.65%
+32.65%

More News

Read More
Agios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease
From GlobeNewswire News Releases
Agios Submits Supplemental New Drug Application to FDA for TIBSOVO® (ivosidenib tablets) for Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
From GlobeNewswire News Releases
Agios Recognizes 14th Annual Rare Disease Day and Raises Awareness of Unmet Needs in Rare Hemolytic Anemias
From GlobeNewswire News Releases
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Agios to Present at March Investor Conferences
From GlobeNewswire News Releases
Agios to Webcast Conference Call of Fourth Quarter and Year End 2020 Financial Results on February 25, 2021
From GlobeNewswire News Releases
Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused
From GlobeNewswire News Releases
Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
From GlobeNewswire News Releases
XBI, VIR, LGND, AGIO: ETF Outflow Alert
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.